Form 8-K - Current report:
SEC Accession No. 0000950170-25-001712
Filing Date
2025-01-06
Accepted
2025-01-06 08:05:24
Documents
13
Period of Report
2025-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K catx-20250102.htm   iXBRL 8-K 56515
2 EX-99.1 catx-ex99_1.htm EX-99.1 21635
3 GRAPHIC img236230851_0.jpg GRAPHIC 22960
  Complete submission text file 0000950170-25-001712.txt   229925

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20250102.xsd EX-101.SCH 23963
15 EXTRACTED XBRL INSTANCE DOCUMENT catx-20250102_htm.xml XML 4534
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33407 | Film No.: 25509101
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)